← Evidence map

ArticleLeukemia2006

Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy.

L Lhermitte et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

this papertrialcites it

2 trials

NCT02661022phase 1/phase 29 enrolled2016 NCT06414681early_phase 120 enrolled2025

Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy. | OpenQuestion